Home/ Supplements/ Omega 3/ ProEFA Junior

ProEFA Junior

product on market Softgel Capsule Nordic Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product provides a blend of omega-3, 6, and 9 fatty acids. Strong evidence supports the role of omega-3s in supporting cognitive development and cardiovascular health in children. The overall ingredient profile is considered safe for general consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for ProEFA Junior
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
45
Servings
Fat/Fatty Acid
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
9 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Omega-6 Fatty Acids
123 mg
Omega-9 Fatty Acids
122 mg

Other Ingredients

purified deep sea Fish Oil Softgel Capsule Borage seed Oil natural Lemon flavor D-Alpha-Tocopherol Rosemary extract
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

How To Take It: Take 2 softgels daily, or as recommended by your healthcare provider.

Formulation Notes

135 EPA/90 DHA/35 GLA

Great for Ages 5+

Pediatric Support

Less than 5 mg of Cholesterol per serving.

No gluten, milk derivatives, or artificial colors or flavors.

Additional Information

Better absorption True triglyceride Great taste!

Supports Learning and Lanuage Helps Maintain a Healthy Immune System

500 mg

Metadata

Product Details

DSLD Entry Date2019-08-23
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID206027
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.